Salesforce (CRM)
247.46
+8.74 (3.66%)
NYSE · Last Trade: Dec 5th, 12:19 AM EST
Detailed Quote
| Previous Close | 238.72 |
|---|---|
| Open | 243.68 |
| Bid | 249.00 |
| Ask | 249.78 |
| Day's Range | 237.60 - 248.97 |
| 52 Week Range | 221.96 - 369.00 |
| Volume | 20,912,190 |
| Market Cap | 231.87B |
| PE Ratio (TTM) | 32.99 |
| EPS (TTM) | 7.5 |
| Dividend & Yield | 1.664 (0.67%) |
| 1 Month Average Volume | 7,860,173 |
Chart
About Salesforce (CRM)
Salesforce is a leading cloud-based software company that specializes in customer relationship management (CRM) solutions. It provides a comprehensive suite of applications designed to help businesses manage their sales, marketing, customer service, and analytics more effectively. By leveraging innovative technologies such as artificial intelligence and automation, Salesforce enables organizations to streamline their processes, enhance customer engagement, and drive growth. The company is committed to delivering a robust platform that allows businesses of all sizes to connect with their customers and gain valuable insights from data, ultimately fostering lasting relationships and improving overall business performance. Read More
News & Press Releases
Salesforce (NYSE: CRM), the world’s #1 AI CRM, today announced that its board of directors declared a quarterly cash dividend of $0.416 per share. The dividend is payable January 8, 2026 to shareholders of record on December 18, 2025.
By Salesforce · Via Business Wire · December 4, 2025
A strong Q3 may have it headed in the right direction.
Via Talk Markets · December 4, 2025
Salesforce (NYSE: CRM), the world’s #1 CRM, today announced that AstraZeneca (LSE/STO/Nasdaq: AZN), a global, science-led biopharmaceutical company, has selected Agentforce Life Sciences for Customer Engagement to help transform its customer engagement globally, fostering stronger relationships with healthcare professionals (HCPs) through data-driven, AI-powered engagement. This work will support AstraZeneca's commitment to push the boundaries of science to deliver life-changing medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal and metabolism, and respiratory and immunology.
By Salesforce · Via Business Wire · December 4, 2025
One trader cited fiscal strength and an aggressive buyback plan.
Via Investor's Business Daily · December 4, 2025
Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.
Via Chartmill · December 4, 2025
The financial markets on December 4, 2025, are experiencing a dynamic session, characterized by a complex interplay of corporate earnings reports, influential analyst updates, and a barrage of new economic data. This confluence of factors is creating a volatile environment, challenging investors to decipher conflicting signals regarding the health of
Via MarketMinute · December 4, 2025
December 4, 2025 – The U.S. stock market is navigating a period of heightened anticipation and volatility today, as investors eagerly await a potential interest rate cut from the Federal Reserve. Major indices are showing mixed signals, reflecting a delicate balance between optimistic expectations for looser monetary policy and underlying
Via MarketMinute · December 4, 2025
Let's have a look at the S&P500 stocks with an unusual volume in today's session.
Via Chartmill · December 4, 2025
Salesforce (NYSE: CRM) shares rose after reporting upbeat Q3 results and raising FY26 outlook. Analysts maintain Buy ratings with targets up to $400.
Via Benzinga · December 4, 2025
December 4, 2025 – In a move that has sent ripples across the global financial markets, Meta Platforms (NASDAQ: META) experienced a significant stock surge today, with shares climbing between 4% and 7%. This robust performance is largely attributed to a strategic re-evaluation by CEO Mark Zuckerberg, signaling a substantial pivot
Via MarketMinute · December 4, 2025
Salesforce (CRM) Q3 earnings exceeded expectations, with Agentforce adoption skyrocketing, reaching $540M ARR and 50% paid transactions.
Via Benzinga · December 4, 2025
Via Benzinga · December 4, 2025
Salesforce shares are rising Thursday following the company's third-quarter report, which topped estimates and showed continued growth ahead.
Via Benzinga · December 4, 2025
Salesforce rival SAP logs a growth ranking jump to the 90th percentile amid its EU AI Cloud launch and robust Q3 cloud revenue results.
Via Benzinga · December 4, 2025
Nasdaq, S&P 500 Futures Pause Ahead Of Key Jobs Data: Why CRM, SNOW, NFLX, MSFT, AI Are On Traders' Radarstocktwits.com
Via Stocktwits · December 4, 2025
Salesforce smashes 'pilot purgatory' fears with 70% AI production growth and a record pipeline in Q3, sending shares surging.
Via Benzinga · December 4, 2025
A surprise drop in private-sector jobs pushed rate-cut expectations even higher and lifted stocks, even as fresh doubts about enterprise AI spending knocked Microsoft lower. Under the surface, chipmakers, retailers, and high-growth software names showed just how narrow and rotational this market still is.
Via Chartmill · December 4, 2025
U.S. stock futures mixed. Kroger, UiPath, Dollar General, Salesforce, and Hormel expected to release earnings.
Via Benzinga · December 4, 2025
CRM software giant Salesforce (NYSE:CRM) met Wall Streets revenue expectations in Q3 CY2025, with sales up 8.6% year on year to $10.26 billion. The company expects next quarter’s revenue to be around $11.18 billion, coming in 2.5% above analysts’ estimates. Its non-GAAP profit of $3.25 per share was 13.6% above analysts’ consensus estimates.
Via StockStory · December 4, 2025
The shares rose about 8% in late trading after the company’s outlook and third‑quarter results topped Wall Street estimates.
Via Talk Markets · December 3, 2025
CRM, SNOW, PATH, IRBT, NFLX were among the stocks seen trending among investors on Wednesday, Dec. 3, 2025.
Via Benzinga · December 3, 2025
The two companies are joining forces to build a comprehensive AI ecosystem.
Via The Motley Fool · December 3, 2025
TORONTO, ON - December 3, 2025 - Enterprise organizations are finally solving a problem that emerged during the remote work transition: hundreds of hours of training videos that employees recorded but can never find. Docsie, an AI-powered knowledge orchestration platform, reports a significant surge in requests for enterprise platform integrations as companies seek to convert scattered video libraries into searchable documentation.
Via AB Newswire · December 3, 2025
The U.S. labor market delivered an unexpected jolt to the economy last month, as small businesses, the traditional engine of job creation, shed a staggering 120,000 positions in November 2025. This significant contraction, revealed in the latest ADP National Employment Report, has immediately amplified concerns about a decelerating
Via MarketMinute · December 3, 2025
CRM software giant Salesforce (NYSE:CRM) met Wall Streets revenue expectations in Q3 CY2025, with sales up 8.6% year on year to $10.26 billion. The company expects next quarter’s revenue to be around $11.18 billion, coming in 2.5% above analysts’ estimates. Its non-GAAP profit of $3.25 per share was 13.6% above analysts’ consensus estimates.
Via StockStory · December 3, 2025